FIG. 5.

Quantification of CD11b⁺ ([A] monocytes, macrophages, and neutrophils), CD14⁺ ([B] monocytes or macrophages), CD16⁺ ([C] NK cells), and CD3ε⁺ ([D] T lymphocytes) cells in dispersed cell preparations of macaque CL collected 3 days after Antide treatment alone or with progestin (A+R5020) or estrogen (A+DPN/PPT) replacement (mean ± SEM, n = 3–4/group). Different letters indicate significant differences in numbers of CD11b⁺, CD14⁺, and CD16⁺ cells between treatment groups (P < 0.05). There were no significant differences in CD3ε⁺ cells between treatments.